These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15204700)
21. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs. He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976 [TBL] [Abstract][Full Text] [Related]
23. Disposition and metabolism of benoxaprofen in laboratory animals and man. Chatfield DH; Green JN Xenobiotica; 1978 Mar; 8(3):133-44. PubMed ID: 418580 [TBL] [Abstract][Full Text] [Related]
24. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of metabolism and disposition of GDC-0152 in rats using 14C labeling strategy at two different positions: a novel formation of hippuric acid from 4-phenyl-5-amino-1,2,3-thiadiazole. Yue Q; Mulder T; Rudewicz PJ; Solon E; Budha N; Ware JA; Lyssikatos J; Hop CE; Wong H; Khojasteh SC Drug Metab Dispos; 2013 Feb; 41(2):508-17. PubMed ID: 23223496 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog. Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917 [TBL] [Abstract][Full Text] [Related]
27. Metabolic disposition of isoxicam in man, monkey, dog, and rat. Borondy PE; Michniewicz BM Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211 [TBL] [Abstract][Full Text] [Related]
28. The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans. Mayo BC; Biggs SR; Chasseaud LF; Hawkins DR; Darragh A; O'Kelly DA Xenobiotica; 1980 Dec; 10(12):873-88. PubMed ID: 7210700 [TBL] [Abstract][Full Text] [Related]
29. Species differences in the pharmacokinetics and metabolism of reparixin in rat and dog. Midgley I; Fitzpatrick K; Wright SJ; John BA; Peard AJ; Major RM; Holding JD; McBurney A; Anacardio R; Novellini R; Ferrari MP Xenobiotica; 2006 May; 36(5):419-40. PubMed ID: 16854780 [TBL] [Abstract][Full Text] [Related]
30. Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey. Paulson SK; Zhang JY; Jessen SM; Lawal Y; Liu NW; Dudkowski CM; Wang YF; Chang M; Yang D; Findlay JW; Berge MA; Markos CS; Breau AP; Hribar JD; Yuan J Xenobiotica; 2000 Jul; 30(7):731-44. PubMed ID: 10963063 [TBL] [Abstract][Full Text] [Related]
31. [Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)]. Hammer R; Bozler G; Jauch R; Koss FW; Hadamovsky H Arzneimittelforschung; 1978; 28(5a):899-903. PubMed ID: 581988 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Walker DK; Ackland MJ; James GC; Muirhead GJ; Rance DJ; Wastall P; Wright PA Xenobiotica; 1999 Mar; 29(3):297-310. PubMed ID: 10219969 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man. Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271 [TBL] [Abstract][Full Text] [Related]
35. Species differences in metabolism of a new antiepileptic drug candidate, DSP-0565 [2-(2'-fluoro[1,1'-biphenyl]-2-yl)acetamide]. Yahata M; Ishii Y; Nakagawa T; Watanabe T; Bando K Biopharm Drug Dispos; 2019 May; 40(5-6):165-175. PubMed ID: 30924154 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration. Okuyama Y; Momota K; Morino A Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546 [TBL] [Abstract][Full Text] [Related]
37. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
38. Disposition of a silicon-containing amide, an inhibitor of acyl-CoA: cholesterol acyltransferase, in dog and rat. Tse FL; Jaffe JM Biopharm Drug Dispos; 1987; 8(5):437-48. PubMed ID: 3663880 [TBL] [Abstract][Full Text] [Related]
39. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy. Muñana KR; Nettifee-Osborne JA; Papich MG J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374 [TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent. Nicolas JM; Collart P; Gerin B; Mather G; Trager W; Levy R; Roba J Drug Metab Dispos; 1999 Feb; 27(2):250-4. PubMed ID: 9929511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]